Low-dose IL-2 as a therapeutic agent for tolerance induction

Thomas R. Malek; Alberto Pugliese

doi:10.2217/imt.11.120

Low-dose IL-2 as a therapeutic agent for tolerance induction

Research output: Contribution to journal › Review article › peer-review

Original language	English (US)
Pages (from-to)	1281-1284
Number of pages	4
Journal	Immunotherapy
Volume	3
Issue number	11
DOIs	https://doi.org/10.2217/imt.11.120
State	Published - Nov 1 2011

Keywords

IL-2
T regulatory cells
tolerance
Type 1 diabetes

ASJC Scopus subject areas

Immunology and Allergy
Oncology
Immunology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2217/imt.11.120

Cite this

@article{7f2ecac5f5cf4f9d96c986bbdff18565,

title = "Low-dose IL-2 as a therapeutic agent for tolerance induction",

keywords = "IL-2, T regulatory cells, tolerance, Type 1 diabetes",

author = "Malek, {Thomas R.} and Alberto Pugliese",

year = "2011",

month = nov,

day = "1",

doi = "10.2217/imt.11.120",

language = "English (US)",

volume = "3",

pages = "1281--1284",

journal = "Immunotherapy",

issn = "1750-743X",

publisher = "Future Medicine Ltd.",

number = "11",

}

TY - JOUR

T1 - Low-dose IL-2 as a therapeutic agent for tolerance induction

AU - Malek, Thomas R.

AU - Pugliese, Alberto

PY - 2011/11/1

Y1 - 2011/11/1

KW - IL-2

KW - T regulatory cells

KW - tolerance

KW - Type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=80755189357&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80755189357&partnerID=8YFLogxK

U2 - 10.2217/imt.11.120

DO - 10.2217/imt.11.120

M3 - Review article

C2 - 22053878

AN - SCOPUS:80755189357

VL - 3

SP - 1281

EP - 1284

JO - Immunotherapy

JF - Immunotherapy

SN - 1750-743X

IS - 11

ER -

Low-dose IL-2 as a therapeutic agent for tolerance induction

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this